613 / 1224
1. MBDCAs were NOT developed for single source dosimetry.
2. Such tests are there to introduce you to MBDCA mechanics and serve as a sanity
check (correct source, changes with TPS version change, etc).
3. You can review test case results as:
local D diff. (to highlight diffs)
global D dif. (to factor in their relative importance)
plan metrics such as DVH and associated indices (to review their clinical significance)
4. MBDCAs do improve dosimetric accuracy relative to TG-43
5. Potential clinical benefit is treatment site- and patient- specific.